MMP3 as a new target of Danshensu/tetramethylpyrazine derivative for attenuating cardiac fibrosis post-myocardial infarction
Tetramethylpyrazine
MMP3
Cardiac Fibrosis
Myocardial fibrosis
Derivative (finance)
DOI:
10.1016/j.lfs.2025.123570
Publication Date:
2025-03-19T00:15:46Z
AUTHORS (12)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (44)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....